Literature DB >> 29570013

Value of pituitary gland MRI at 7 T in Cushing's disease and relationship to inferior petrosal sinus sampling: case report.

Meng Law1, Regina Wang2, Chia-Shang J Liu1, Mark S Shiroishi1, John D Carmichael3, William J Mack4, Martin Weiss3, Danny J J Wang2, Arthur W Toga2, Gabriel Zada4.   

Abstract

Cushing's disease is caused by adrenocorticotrophic hormone (ACTH)-secreting pituitary adenomas, which are often difficult to identify on standard 1.5-T or 3-T MRI, including dynamic contrast imaging. Inferior petrosal and cavernous sinus sampling remains the gold standard for MRI-negative Cushing's disease.The authors report on a 27-year-old woman with Cushing's disease in whom the results of standard 1.5-T and 3-T MRI, including 1.5-T dynamic contrast imaging, were negative. Inferior petrosal sinus sampling showed a high central-to-peripheral ACTH ratio (148:1) as well as a right-to-left ACTH gradient (19:1), suggesting a right-sided pituitary microadenoma. The patient underwent 7-T MRI, which showed evidence of a right-sided pituitary lesion with focal hypoenhancement not visualized on 1.5-T or 3-T MRI. The patient underwent an endoscopic endonasal transsphenoidal operation, with resection of a right-sided pituitary mass. Postoperatively, she developed clinical symptoms suggestive of adrenal insufficiency and a nadir cortisol level of 1.6 μg/dl on postoperative day 3, and hydrocortisone therapy was initiated. Permanent histopathology specimens showed Crooke's hyaline change and ACTH-positive cells suggestive of an adenoma.MRI at 7 T may be beneficial in identifying pituitary microadenoma location in cases of standard 1.5-T and 3-T MRI-negative Cushing's disease. In the future, 7-T MRI may preempt inferior petrosal sinus sampling and help in cases of standard and dynamic contrast 1.5-T and 3-T MRI-negative Cushing's disease.

Entities:  

Keywords:  7-T MRI; ACTH = adrenocorticotropic hormone; Cushing’s disease; GBCA = gadolinium-based contrast agent; IPSS = inferior petrosal sinus sampling; POD = postoperative day; RF = radiofrequency; TSE = turbo spin echo; pituitary surgery

Year:  2018        PMID: 29570013      PMCID: PMC6483888          DOI: 10.3171/2017.9.JNS171969

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.408


  19 in total

Review 1.  The role of inferior petrosal sinus sampling in the diagnostic localization of Cushing's disease.

Authors:  Shivanand P Lad; Chirag G Patil; Edward R Laws; Laurence Katznelson
Journal:  Neurosurg Focus       Date:  2007       Impact factor: 4.047

2.  Cavernous and inferior petrosal sinus sampling and dynamic magnetic resonance imaging in the preoperative evaluation of Cushing's disease.

Authors:  Matthew B Potts; Jugal K Shah; Annette M Molinaro; Lewis S Blevins; J Blake Tyrrell; Sandeep Kunwar; Christopher F Dowd; Steven W Hetts; Manish K Aghi
Journal:  J Neurooncol       Date:  2014-01-08       Impact factor: 4.130

Review 3.  The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states.

Authors:  J Newell-Price; P Trainer; M Besser; A Grossman
Journal:  Endocr Rev       Date:  1998-10       Impact factor: 19.871

4.  Initial experience of 3 Tesla versus conventional field strength magnetic resonance imaging of small functioning pituitary tumours.

Authors:  David B Stobo; Robert S Lindsay; John M Connell; Laurence Dunn; Kirsten P Forbes
Journal:  Clin Endocrinol (Oxf)       Date:  2011-11       Impact factor: 3.478

5.  Dynamic and conventional spin-echo MR of pituitary microlesions.

Authors:  W S Bartynski; L Lin
Journal:  AJNR Am J Neuroradiol       Date:  1997-05       Impact factor: 3.825

6.  Spoiled gradient recalled acquisition in the steady state technique is superior to conventional postcontrast spin echo technique for magnetic resonance imaging detection of adrenocorticotropin-secreting pituitary tumors.

Authors:  Nicholas Patronas; Nail Bulakbasi; Constantine A Stratakis; Antony Lafferty; Edward H Oldfield; John Doppman; Lynnette K Nieman
Journal:  J Clin Endocrinol Metab       Date:  2003-04       Impact factor: 5.958

7.  Dynamic contrast-enhanced MR imaging of the pituitary gland with fast spin-echo technique.

Authors:  W L Davis; J N Lee; B D King; H R Harnsberger
Journal:  J Magn Reson Imaging       Date:  1994 May-Jun       Impact factor: 4.813

Review 8.  Cushing's disease: a surgical view.

Authors:  D K Lüdecke; J Flitsch; U J Knappe; W Saeger
Journal:  J Neurooncol       Date:  2001-09       Impact factor: 4.130

9.  The accuracy of CT and MR evaluation of the sella turcica for detection of adrenocorticotropic hormone-secreting adenomas in Cushing disease.

Authors:  M Buchfelder; R Nistor; R Fahlbusch; W J Huk
Journal:  AJNR Am J Neuroradiol       Date:  1993 Sep-Oct       Impact factor: 3.825

Review 10.  Bilateral inferior petrosal sinus sampling.

Authors:  Benedetta Zampetti; Erika Grossrubatscher; Paolo Dalino Ciaramella; Edoardo Boccardi; Paola Loli
Journal:  Endocr Connect       Date:  2016-06-27       Impact factor: 3.335

View more
  3 in total

Review 1.  Pitfalls in Performing and Interpreting Inferior Petrosal Sinus Sampling: Personal Experience and Literature Review.

Authors:  Jordan E Perlman; Philip C Johnston; Ferdinand Hui; Guy Mulligan; Robert J Weil; Pablo F Recinos; Divya Yogi-Morren; Roberto Salvatori; Debraj Mukherjee; Gary Gallia; Laurence Kennedy; Amir H Hamrahian
Journal:  J Clin Endocrinol Metab       Date:  2021-04-23       Impact factor: 5.958

2.  Utility of 7 Tesla MRI for Preoperative Planning of Endoscopic Endonasal Surgery for Pituitary Adenomas.

Authors:  John W Rutland; Bradley N Delman; Rebecca E Feldman; Nadejda Tsankova; Hung-Mo Lin; Francesco Padormo; Raj K Shrivastava; Priti Balchandani
Journal:  J Neurol Surg B Skull Base       Date:  2019-11-21

Review 3.  Clinical 7 T MRI: Are we there yet? A review about magnetic resonance imaging at ultra-high field.

Authors:  Giuseppe Barisano; Farshid Sepehrband; Samantha Ma; Kay Jann; Ryan Cabeen; Danny J Wang; Arthur W Toga; Meng Law
Journal:  Br J Radiol       Date:  2018-11-01       Impact factor: 3.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.